I forgot to mention the possible follow up phone call by Amgen CEO to Amgen Chairman
Amgen CEO: Just got a call from Roger from PAB about suggesting licencing arrangement for PAT-SC1.....
Amgen Chairman: You didn't let on that we are looking at takeover of PAB?
Amgen CEO: No. Don't reckon he has a clue, reckon we can easily pick up PAB and PAT-SM6 and PAT-SC1 for under $100m as shareholders will be lining up to get out I reckon after last 12 months they have had. Gives us portfolio of cancer drug candidates that fits very nicely with our portfolio and at bargain basement price.
Amgen Chairman: Ok but keep it under raps, we need to keep the share price down so we don't pay over the odds.
Ann: Patrys 2014 AGM Presentation, page-56
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $3.117K | 1.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 44343144 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10764841 | 13 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |